DE69400356T2 - Quervernetzte amylose als bindemittel/sprengmittel fuer tabletten - Google Patents

Quervernetzte amylose als bindemittel/sprengmittel fuer tabletten

Info

Publication number
DE69400356T2
DE69400356T2 DE69400356T DE69400356T DE69400356T2 DE 69400356 T2 DE69400356 T2 DE 69400356T2 DE 69400356 T DE69400356 T DE 69400356T DE 69400356 T DE69400356 T DE 69400356T DE 69400356 T2 DE69400356 T2 DE 69400356T2
Authority
DE
Germany
Prior art keywords
cross
agent
tablets
linked amylose
binding agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69400356T
Other languages
English (en)
Other versions
DE69400356D1 (de
Inventor
Louis Cartilier
Mircea Mateescu
Yves Dumoulin
Vincent Lenaerts
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Labopharm Inc
Original Assignee
Labopharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labopharm Inc filed Critical Labopharm Inc
Application granted granted Critical
Publication of DE69400356D1 publication Critical patent/DE69400356D1/de
Publication of DE69400356T2 publication Critical patent/DE69400356T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
DE69400356T 1993-03-25 1994-03-22 Quervernetzte amylose als bindemittel/sprengmittel fuer tabletten Expired - Fee Related DE69400356T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/037,119 US5616343A (en) 1993-03-25 1993-03-25 Cross-linked amylose as a binder/disintegrant in tablets
PCT/CA1994/000163 WO1994021236A1 (en) 1993-03-25 1994-03-22 Cross-linked amylose as a binder/disintegrant in tablets

Publications (2)

Publication Number Publication Date
DE69400356D1 DE69400356D1 (de) 1996-09-12
DE69400356T2 true DE69400356T2 (de) 1996-11-28

Family

ID=21892532

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69400356T Expired - Fee Related DE69400356T2 (de) 1993-03-25 1994-03-22 Quervernetzte amylose als bindemittel/sprengmittel fuer tabletten

Country Status (17)

Country Link
US (1) US5616343A (de)
EP (1) EP0689429B1 (de)
JP (1) JP2831851B2 (de)
CN (1) CN1119828A (de)
AT (1) ATE141046T1 (de)
AU (1) AU679732B2 (de)
CA (1) CA2155210A1 (de)
CZ (1) CZ285201B6 (de)
DE (1) DE69400356T2 (de)
ES (1) ES2091142T3 (de)
FI (1) FI954232A0 (de)
GR (1) GR3021433T3 (de)
HU (1) HUT73667A (de)
NO (1) NO953767D0 (de)
NZ (1) NZ262876A (de)
PL (1) PL310815A1 (de)
WO (1) WO1994021236A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL119660A (en) 1993-05-10 2002-09-12 Euro Celtique Sa Controlled release formulation comprising tramadol
CA2173818A1 (fr) * 1996-04-10 1997-10-11 Francois Chouinard Comprime pharmaceutique a liberation controlee contenant un support a base d'amylose reticule et d'hydroxypropylmethylcellulose
DE19640062B4 (de) * 1996-09-28 2006-04-27 Lts Lohmann Therapie-Systeme Ag Orale Zubereitung, enthaltend in einer in wässrigem Medium quellbaren Matrix wenigstens einen pharmazeutischen Wirkstoff
US5879707A (en) * 1996-10-30 1999-03-09 Universite De Montreal Substituted amylose as a matrix for sustained drug release
US6077537A (en) * 1997-05-21 2000-06-20 Warner-Lambert Company Non-sedating acrivastine product
US5989589A (en) * 1997-10-24 1999-11-23 Cartilier; Louis Cross-linked cellulose as a tablet excipient
US6284273B1 (en) * 1998-02-24 2001-09-04 Vincent Lenaerts Cross-linked high amylose starch resistant to amylase as a matrix for the slow release of biologically active compounds
CA2393231A1 (en) 1999-12-06 2001-06-07 Edward Mendell Co., Inc. Pharmaceutical superdisintegrant
US6607748B1 (en) * 2000-06-29 2003-08-19 Vincent Lenaerts Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
TWI319713B (en) * 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
US8487002B2 (en) * 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
US6846497B2 (en) 2003-01-30 2005-01-25 National Starch And Chemical Investment Holding Corporation Rapidly expanding starches with altered crystalline structure
US20070071810A1 (en) * 2003-08-26 2007-03-29 Kenichi Kudo Additive for tablets
NO319624B1 (no) * 2003-09-15 2005-09-05 Trouw Internat Bv Fiskefôr for laksefisk i ferskvann og anvendelse av slikt fôr.
US20060172006A1 (en) * 2003-10-10 2006-08-03 Vincent Lenaerts Sustained-release tramadol formulations with 24-hour clinical efficacy
US8871270B2 (en) * 2004-07-09 2014-10-28 Corn Products Development, Inc Tablet excipient
CA2491665A1 (fr) * 2004-12-24 2006-06-24 Louis Cartilier Formulation de comprime pour liberation soutenue de principe actif
EP1717215A1 (de) * 2005-04-19 2006-11-02 Lafarge Verfahren zur Kompaktieren von hydraulischen Bindemitteln und gemahlene Tabletten
BRPI0615860B8 (pt) * 2005-09-09 2021-05-25 Labopharm Barbados Ltd composição farmacêutica de liberação prolongada monolítica sólida
AU2008314454A1 (en) * 2007-10-16 2009-04-23 Labopharm (Barbados) Limited Bilayer composition for the sustained release of acetaminophen and tramadol
BRPI0821732A2 (pt) 2007-12-17 2015-06-16 Labopharm Inc Formulações de liberação controlada , forma de dosagem sólida, e, uso da formulação de liberação controlada
WO2009123102A1 (ja) 2008-03-31 2009-10-08 旭化成ケミカルズ株式会社 崩壊性に優れる加工澱粉粉末及びその製法
AU2009327312A1 (en) 2008-12-16 2011-08-04 Labopharm Europe Limited Misuse preventative, controlled release formulation
BR112013000190A2 (pt) 2010-07-06 2017-11-07 Gruenenthal Gmbh formas de dosagem de retenção gástrica compreendendo um análogo de gaba e um opioide
AR082167A1 (es) 2010-07-14 2012-11-14 Gruenenthal Gmbh Formas de dosificacion gastrorretentivas
CN108456050A (zh) * 2018-01-24 2018-08-28 天津水泥工业设计研究院有限公司 一种低成本的生产圆颗粒矿物肥料的造粒添加剂

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2987445A (en) * 1958-10-10 1961-06-06 Rohm & Haas Drug composition
US3087860A (en) * 1958-12-19 1963-04-30 Abbott Lab Method of prolonging release of drug from a precompressed solid carrier
US3622677A (en) * 1969-07-07 1971-11-23 Staley Mfg Co A E Compressed tablets containing compacted starch as binder-disintegrant ingredient
US4072535A (en) * 1970-12-28 1978-02-07 A. E. Staley Manufacturing Company Precompacted-starch binder-disintegrant-filler material for direct compression tablets and dry dosage capsules
US4088798A (en) * 1975-11-11 1978-05-09 Sandoz, Inc. Methods for the preparation of controlled gastric residence time medicament formulations
US4230687A (en) * 1978-05-30 1980-10-28 Griffith Laboratories U.S.A., Inc. Encapsulation of active agents as microdispersions in homogeneous natural polymeric matrices
JPS6042766B2 (ja) * 1978-12-09 1985-09-25 日本化薬株式会社 基剤
US4369308A (en) * 1981-07-24 1983-01-18 National Starch And Chemical Corporation Low swelling starches as tablet disintegrants
US4713249A (en) * 1981-11-12 1987-12-15 Schroeder Ulf Crystallized carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof
GB8319766D0 (en) * 1983-07-22 1983-08-24 Graham N B Controlled release device
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4933185A (en) * 1986-09-24 1990-06-12 Massachusetts Institute Of Technology System for controlled release of biologically active compounds
US4761289A (en) * 1986-10-10 1988-08-02 International Minerals & Chemical Corp. Sustained release implant and method for preparing same
US4755397A (en) * 1986-12-24 1988-07-05 National Starch And Chemical Corporation Starch based particulate encapsulation process
US4812445A (en) * 1987-02-06 1989-03-14 National Starch And Chemical Corporation Starch based encapsulation process
GB8812490D0 (en) * 1988-05-26 1988-06-29 Agricultural & Food Res Delayed release formulations
CA2041774C (en) * 1990-11-27 1994-04-19 Mircea A. Mateescu Use of cross-linked amylose as a matrix for the slow release of biologically active compounds
CA2032385A1 (en) * 1990-12-17 1992-06-18 Chung Wai-Chiu Enzymatically debranched starches as tablet excipients

Also Published As

Publication number Publication date
GR3021433T3 (en) 1997-01-31
PL310815A1 (en) 1996-01-08
EP0689429B1 (de) 1996-08-07
HU9502790D0 (en) 1995-11-28
AU6279994A (en) 1994-10-11
NO953767L (no) 1995-09-22
JP2831851B2 (ja) 1998-12-02
HUT73667A (en) 1996-09-30
DE69400356D1 (de) 1996-09-12
CN1119828A (zh) 1996-04-03
FI954232A (fi) 1995-09-08
NO953767D0 (no) 1995-09-22
CA2155210A1 (en) 1994-09-29
AU679732B2 (en) 1997-07-10
ATE141046T1 (de) 1996-08-15
CZ285201B6 (cs) 1999-06-16
CZ248695A3 (en) 1996-01-17
NZ262876A (en) 1997-01-29
US5616343A (en) 1997-04-01
EP0689429A1 (de) 1996-01-03
ES2091142T3 (es) 1996-10-16
WO1994021236A1 (en) 1994-09-29
JPH08507769A (ja) 1996-08-20
FI954232A0 (fi) 1995-09-08

Similar Documents

Publication Publication Date Title
DE69400356D1 (de) Quervernetzte amylose als bindemittel/sprengmittel fuer tabletten
NO20004208D0 (no) Fornettet stivelse med høyt amyloseinnhold og med funksjonelle grupper som en matriks for frigivning av farmasøytiske midler
SI0929565T1 (en) Nitrate esters of corticoid compounds and pharmaceutical applications thereof
CA2041774A1 (en) Use of cross-linked amylose as a matrix for the slow release of biologically active compounds
TR199801399T2 (xx) Yeni 19-nor-pregnen t�revleri.
CZ15295A3 (en) Solid pharmaceutical dosing unit
TR199900161T2 (xx) T�bbi �r�nler �retimi i�in aminler.
BG105570A (en) Pharmaceutical compositions for modified release insulin sensitiser
PT1017667E (pt) 2-amino-6-metil-7-acetil-tetralina e composicoes farmaceuticas para a prevencao e para o tratamento terapeutico de patologias inflamatorias e/ou de natureza autoimunitaria
DE3784674D1 (de) Komplexe von wismut- oder antimonhalogeniden mit aminen nuetzlich als flammenverzoegerer fuer polymere, und diese enthaltende polymer-zusammensetzungen.
FR2705895B1 (fr) Comprimés médicamenteux exempts d'agent lubrifiant.
ES2062804T3 (es) Medicamento recubierto con gelatina y procedimiento para fabricar el mismo.
ES1015632U (es) Utensilio para la manicura.
UA28773A (uk) Спосіб лікування неспецифічного виразкового коліту
ES1011408U (es) Zocalo corto-circuitable para descargador de gas.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee